CoChat

Serum levels of C‐peptide, IGFBP‐1 and IGFBP‐2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition

Open access
Cust, Anne E., Allen, Naomi E., Rinaldi, Sabina, Dossus, Laure, Friedenreich, Christine, Olsen, Anja, Tjønneland, Anne, Overvad, Kim, Clavel‐Chapelon, Françoise, Boutron‐Ruault, Marie‐Christine, Linseisen, Jakob, Chang‐Claude, Jenny, Boeing, Heiner, Schulz, Mandy, Benetou, Vassiliki, Trichopoulou, Antonia, Trichopoulos, Dimitrios, Palli, Domenico, Berrino, Franco, Tumino, Rosario, Mattiello, Amalia, Vineis, Paolo, Quirós, J. Ramón, Agudo, Antonio, Sánchez, Maria‐Jose, Larrañaga, Nerea, Navarro, Carmen, Ardanaz, Eva, Bueno‐de‐Mesquita, H. Bas, Peeters, Petra H.M., van Gils, Carla H., Bingham, Sheila, Khaw, Kay‐Tee, Key, Tim, Slimani, Nadia, Riboli, Elio, Kaaks, Rudolf · 2007 · International Journal of Cancer
Cited by 102

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

We conducted a case‐control study nested within the European Prospective Investigation into Cancer and Nutrition, to examine the associations between prediagnostic serum concentrations of C‐peptide, insulin‐like growth factor binding protein (IGFBP)‐1 and IGFBP‐2, and endometrial cancer risk. Among pre‐ and post‐menopausal women, who were not currently using exogenous hormones, 286 women developed incident endometrial cancer during an average 5.1 years follow‐up. Using risk set sampling, 555 matched control subjects were selected. In conditional logistic regression models adjusted for matching factors only, endometrial cancer risk increased with increasing serum levels of C‐peptide (relative risks (RR) for the top vs. bottom quartile = 2.13 [95% confidence interval (CI) 1.33–3.41], ptrend = 0.001, and decreasing serum levels of IGFBP‐2 (RR for the top vs. bottom quartile = 0.56 [95% CI 0.35–0.90], ptrend = 0.03, but was not significantly associated with IGFBP‐1 levels (RR for the top vs. bottom quartile = 0.76 [95% CI 0.47–1.21], ptrend = 0.25). In BMI‐adjusted models, only the C‐peptide association remained marginally statistically significant (RR for the top vs. bottom quartile = 1.56 [95% CI 0.94–2.57], ptrend = 0.05 for C‐peptide; 0.84 [95% CI 0.50–1.40], ptrend = 0.74 for IGFBP‐2; and 1.08 [95% CI 0.65–1.78], ptrend = 0.86 for IGFBP‐1 levels). These associations were stronger among nonfasting women (≤≤6 hr since last meal; 63% of subjects) but were not evident among fasting women, although the interactions were not statistically significant. The C‐peptide‐risk association was substantially attenuated after adjustment for free estradiol in postmenopausal women (RR for the top vs. bottom quartile = 1.28 [95% CI 0.67–2.45], ptrend = 0.42. Our results provide modest support to the hypothesis that hyperinsulinaemia is a risk factor for endometrial cancer. © 2007 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.22578

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 102

Metadata

Authors
Cust, A. E., Allen, N. E., Rinaldi, S., Dossus, L., Friedenreich, C., Olsen, A., Tjønneland, A., Overvad, K., Clavel‐Chapelon, F., Boutron‐Ruault, M., Linseisen, J., Chang‐Claude, J., Boeing, H., Schulz, M., Benetou, V., Trichopoulou, A., Trichopoulos, D., Palli, D., Berrino, F., Tumino, R., Mattiello, A., Vineis, P., Quirós, J. R., Agudo, A., Sánchez, M., Larrañaga, N., Navarro, C., Ardanaz, E., Bueno‐de‐Mesquita, H. B., Peeters, P. H. M., van Gils, C. H., Bingham, S., Khaw, K., Key, T., Slimani, N., Riboli, E., & Kaaks, R.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2007-04-10
Volume
120
Issue
12
Pages
2656-2664
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2039819173
Cited by
102
References
5
FWCI
3.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum levels of C‐peptide, IGFBP‐1 and IGFBP‐2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition. https://app.cochat.ai/papers/10.1002/ijc.22578
The paper
Cust, A. E., Allen, N. E., Rinaldi, S., Dossus, L., Friedenreich, C., Olsen, A., Tjønneland, A., Overvad, K., Clavel‐Chapelon, F., Boutron‐Ruault, M., Linseisen, J., Chang‐Claude, J., Boeing, H., Schulz, M., Benetou, V., Trichopoulou, A., Trichopoulos, D., Palli, D., Berrino, F., . . . Kaaks, R. (2007). Serum levels of C‐peptide, IGFBP‐1 and IGFBP‐2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition. International Journal of Cancer. https://doi.org/10.1002/ijc.22578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.